KDKelli L. Dominick

Kelli L. Dominick

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kelli L. Dominick has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The association of comorbid conditions with patient-reported outcomes in Veterans with hip and knee osteoarthritis

    by Leah L. Zullig, Hayden B. Bosworth, Amy S. Jeffreys, Leonor Corsino, Cynthia J. Coffman, Eugene Z. Oddone, William S. Yancy, Kelli D. Allen

    There is limited understanding of how comorbid health conditions affect osteoarthritis (OA)-related outcomes. This study examined associations of different comorbidity measures with baseline OA-related patient-reported outcomes (PROs) among patients with hip and knee OA. Data were from patients (N = 300, 9 % female, mean age = 61.1; SD = 9.2) enrolled in a randomized control trial at the Durham Veterans Affairs Medical Center. Separate multivariable regression models, adjusted for demographic and clinical characteristics, examined the association of each comorbidity measure with baseline PROs: pain, physical function, depressive symptoms, fatigue, and insomnia. Comorbidity measures included the Self-Administered Comorbidity Questionnaire (SACQ), conditions reported as activity-limiting (SACQ-AL), and indicators of depression, diabetes, hypertension, and back pain. Mean (SD) numbers of comorbid conditions and activity-limiting conditions were 3.4 (1.8) and 1.6 (1.4), respectively. Comorbidity scores (SACQ overall and SACQ-AL) and individual comorbidity conditions were each associated with worse OA-related PROs adjusting for demographic and clinical factors. Worse SACQ overall and SACQ-AL scores were associated with worse mean scores for pain, depressive symptoms, fatigue, and insomnia (p values p < 0.01). Depression was associated with worse pain (p = 0.03), fatigue, and insomnia (p values p = 0.01), depressive symptoms (p = 0.02), and insomnia (p = 0.03). Back pain was associated with worse pain scores (p = 0.02). Results provide evidence that comorbidity burden, particularly activity-limiting conditions, is associated with worse OA-related PROs. Interventions for patients with OA need to address comorbid conditions and their impact on key outcomes.


  • Pilot Study of Pain and Coping Among Patients With Osteoarthritis

    by Kelli D. Allen, Yvonne M. Golightly, Maren K. Olsen

    Background and Objectives: Few studies have examined patterns of pain and coping among patients with osteoarthritis (OA). This pilot study used a daily diary approach to examine pain and coping strategy use among white and nonwhite veterans with OA. Methods: Participants (23 white, 13 nonwhite; 89% male; mean age = 63 years) completed diaries of pain (10-cm visual analog scale) and coping (total, problem-focused, and emotion-focused) for 30 days. Analyses examined relationships of mean self-reported pain severity and variability with coping strategy use as well as racial differences in these associations. Results: The mean pain level (4.46 [scale of 0–10], standard deviation [SD] = 2.12) and mean within-subject pain variance (1.94, SD = 1.79) were similar between white and nonwhite participants. With respect to pain variability, 2 distinct subgroups were observed, with approximately half of participants reporting high variability and half reporting low variability. The mean total coping score (on a scale of 0–7) was 2.62 (SD = 1.77), with problem-focused strategies being used more often than emotion-focused. There were no significant associations between coping (total, problem-focused, and emotion-focused) and mean pain severity, but the direction of these relationships differed according to race. Conclusion: Results of this pilot study showed considerable between-subject variability in pain and coping strategy use as well as some racial differences. Medical treatment and self-management approaches may be improved if they can be tailored according to patients’ pain patterns and preferred coping strategies.


    • 1 February 2006
      • Vol. 33  (2) , 348-54

    Arthritis prevalence and symptoms among US non-veterans, veterans, and veterans receiving Department of Veterans Affairs Healthcare.

    by Kelli L Dominick, Yvonne M Golightly, George L Jackson

    . Studies suggest arthritis and rheumatic diseases are common among military veterans, but prior research has not directly compared arthritis between veterans and the general population. This study compared arthritis prevalence and symptoms between veterans of the US Armed Forces and non-veterans, and between veterans who are US Department of Veterans Affairs (VA) healthcare users and veteran nonusers. Study participants were 123,395 respondents from 36 states that completed the 2000 Behavioral Risk Factor Surveillance System arthritis module. Analyses compared self-reports of doctor-diagnosed arthritis, chronic joint symptoms, and activity limitation according to veteran status. Analyses also compared relationships of demographic characteristics to arthritis according to veteran status. US veterans were more likely to report doctor-diagnosed arthritis than non-veterans (32% vs 22%; p < 0.001), and VA healthcare users were more likely to report doctor-diagnosed arthritis than veteran nonusers (43% vs 30%; p < 0.001). Differences remained in analyses controlling for demographic characteristics. Among respondents with arthritis, veterans were more likely to report chronic joint symptoms and activity limitation than non-veterans, and VA healthcare users were more likely to report chronic symptoms and activity limitation than veteran nonusers. Demographic factors predicting doctor-diagnosed arthritis were similar among the 3 groups. This study shows a significant burden of arthritis among US veterans, particularly VA healthcare users. Increased prevention of orthopedic injuries in the military may reduce the risk of arthritis in veterans. Within the VA healthcare system, self-management interventions may help to improve outcomes among the many patients with arthritis.


  • Open Access

    Validity, factor structure, and clinical relevance of the AUSCAN osteoarthritis hand index

    by Kelli D. Allen, Joanne M. Jordan, Jordan B. Renner, Virginia B. Kraus

    Objective: The Australian/Canadian (AUSCAN) Osteoarthritis Hand Index is a self‐report assessment of pain, stiffness, and function in patients with hand osteoarthritis (OA). Small studies have confirmed the reliability, construct validity, and responsiveness of this measure, but the factor structure has not been examined. In this study, we examined the clinimetric properties and clinical relevance of the AUSCAN index in a large sample of patients with familial hand OA.Methods: The study group comprised 700 patients (80% female, mean age 69 years) who were part of a study on the genetics of generalized OA. All patients had radiographic hand OA bilaterally. The analyses examined internal consistency, factor structure, and relationships of the subscales to grip and pinch strength and a single‐item pain measure.Results: Internal consistency was high for the total AUSCAN index and the subscales (Cronbach's α = 0.93–0.96). The AUSCAN function subscale had the strongest correlation with grip and pinch strength, and the pain subscale had the strongest correlation with the single‐item pain measure, thus supporting the construct validity of these subscales. Factor analysis showed that all pain and function items clearly loaded on the subscale they were intended to measure. Each 1‐unit increase in the AUSCAN function subscale was associated with a clinically relevant decrease in hand strength.Conclusion: The results of this study strongly confirm the clinimetric properties of the AUSCAN index, including the validity of specific subscales. Results indicate that the AUSCAN index can measure meaningful changes in pain, stiffness, and function.


  • Comparison of three comorbidity measures for predicting health service use in patients with osteoarthritis

    by Kelli L. Dominick, Tara K. Dudley, Cynthia J. Coffman, Hayden B. Bosworth

    Objective: To compare the ability of 3 database‐derived comorbidity scores, the Charlson Score, Elixhauser method, and RxRisk‐V, in predicting health service use among individuals with osteoarthritis (OA).Methods: The study population comprised 306 patients who were under care for OA in the Veterans Affairs (VA) health care system. Comorbidity scores were calculated using 1 year of data from VA inpatient and outpatient databases (Charlson Score, Elixhauser method), as well as pharmacy data (RxRisk‐V). Model selection was used to identify the best comorbidity index for predicting 3 health service use variables: number of physician visits, number of prescriptions used, and hospitalization probability. Specifically, Akaike's Information Criterion (AIC) was used to determine the best model for each health service outcome variable. Model fit was also evaluated.Results: All 3 comorbidity indices were significant predictors of each health service outcome (P < 0.01). However, based on AIC values, models using the RxRisk‐V and Elixhauser indices as predictor variables were better than models using the Charlson Score. The model using the RxRisk‐V index as a predictor was the best for the outcome of prescription medication use, and the model with the Elixhauser index was the best for the outcome of physician visits.Conclusion: The Rx‐Risk‐V and Elixhauser are suitable comorbidity measures for examining health services use among patients with OA. Both indices are derived from administrative databases and can efficiently capture comorbidity among large patient populations.


  • Racial variations in self-reported osteoarthritis symptom severity among veterans

    by Yvonne M. Golightly, Kelli L. Dominick

    Background and aims: This study aimed at examining factors related to osteoarthritis (OA) symptom severity in African American and Caucasian veterans (n=202). Methods: OA symptom severity (lower extremity pain, stiffness, and physical function) was measured by the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). We also examined whether racial differences existed when controlling for other important demographic and clinical variables, including age, gender, income, educational level, employment status, marital status, number of years with OA symptoms, location of arthritic joints (hip, knee, back, foot/ankle), use of exercise, and current use of OA medications. Lastly, we examined whether factors associated with self-reported OA symptom severity differed in African American and Caucasian veterans. Results: The mean WOMAC score for AfricanAmerican veterans (on a scale of 0–96) was 54.6 (SD=17.2), and the mean score for Caucasian veterans was 48.4 (SD=17.6; p=0.02). In a multivariable regression model including demographic and clinical variables, African American veterans had significantly higher WOMAC scores than Caucasians (β=0.185, p=0.009). In Caucasian veterans, greater number of years with OA, presence of hip OA, and a low income were associated with greater WOMAC scores. In African Americans, no use of exercise and the presence of OA in the hip or back were associated with greater WOMAC scores. Conclusions: Among this sample of veterans, African Americans had significantly higher WOMAC scores than Caucasians after controlling for other important demographic and clinical factors. Different and more intense treatment strategies may be needed for African American veterans with OA.


    • 1 January 2005
      • Vol. 15  (1) , 116-22

    Racial differences in analgesic/anti-inflammatory medication adherence among patients with osteoarthritis.

    by Kelli L Dominick, Yvonne M Golightly, Hayden B Bosworth

    This study examined the prevalence of self-reported adherence to medications for osteoarthritis (OA) and racial differences in adherence. This was a cross-sectional survey of 156 Black and White veterans who were taking medications for OA. One quarter of participants reported sometimes forgetting to take their OA medications, 16% were sometimes careless about taking medications, and 27% sometimes stopped taking their medications when they felt better. Overall, 44% of participants reported at least one of these three behaviors. In a multivariable logistic regression model adjusting for demographic factors, OA severity, participatory decision making (PDM), and side effects, Black patients were more likely to report at least one nonadherent behavior (odds ratio [OR] = 2.25, 95% CI = 1.03-4.91). Patients with greater PDM scores were slightly less likely to report nonadherent behavior (OR = 0.95, 95% CI = 0.91-0.99). Additional research is needed to examine factors underlying racial differences in adherence, to guide effective interventions.


    • 1 July 2004
      • Vol. 96  (7) , 928-32

    Racial differences in analgesic/anti-inflammatory medication use and perceptions of efficacy.

    by Kelli L Dominick, Hayden B Bosworth, Jason B Hsieh, Barry K Moser

    Pharmacotherapy is a key component to osteoarthritis (OA) treatment. Research has shown important racial differences in pain thresholds and perceptions, but little is known about racial variations in responses to pain medications. The purpose of this study was to compare perceptions of efficacy of pain medications among African-American and Caucasian veterans with OA. Participants (N = 202; 70% Caucasian, 30% African-American) were under care for OA within the VA healthcare system. Participants rated the helpfulness of current analgesic/anti-inflammatory medications (scale of 1--not at all helpful to 10--very helpful). The mean rating of medication helpfulness was 6.1. African-American participants reported significantly greater ratings of medication helpfulness than Caucasians (6.6 vs. 5.9), controlling for demographics, disease severity, total number of analgesic/anti-inflammatory medications being taken, and the class of the medication. African Americans had somewhat more favorable perceptions of medication helpfulness than Caucasians. However, overall ratings of medication helpfulness were relatively low. Further research is needed to examine whether modifiable factors (such as low dosing or patient nonadherence to prescription instructions) contribute to perceptions of poor efficacy.


  • Nonsteroidal Antiinflammatory Drug Use among Patients with GI Bleeding

    by Kelli L Dominick, Hayden B Bosworth, Amy S Jeffreys, Steven C Grambow, Eugene Z Oddone, Ronnie D Horner

    BACKGROUND: Previous studies have suggested that recommended gastroprotective strategies such as gastroprotective agents (GPAs) and cyclooxygenase (COX) 2 inhibitors may be underutilized among individuals at risk for nonsteroidal antiinflammatory drug (NSAID)-related gastrointestinal (GI) bleeding. OBJECTIVE: To examine the use of traditional NSAIDs, COX-2 inhibitors, and GPAs among patients recently hospitalized for GI bleeding. METHODS: This was a retrospective cohort study of a national sample of 4338 veterans hospitalized for GI bleeding between January and June 1999. Prescription drug use was examined for 6 months following hospitalization. We examined relationships of subject characteristics (age, race, gender, geographic region, diagnosis of arthritis) to prescription of a high-risk NSAID, defined as a traditional NSAID but no GPA within 60 days before or after the NSAID. RESULTS: Approximately 20% of subjects were prescribed an NSAID or COX-2 inhibitor, but only 5% were prescribed a traditional NSAID with no GPA. In a multivariable analysis, subjects <65 years of age and those with arthritis were more likely to be prescribed a traditional NSAID without a GPA. No other subject characteristics were related to receipt of a high-risk prescription. CONCLUSIONS: In a national sample of veterans with a recent hospitalization for GI bleeding, high-risk NSAID prescriptions were uncommon. Underuse of gastroprotective strategies may be more common in patients with less recent GI bleeding—related hospitalization. Strategies to remind physicians and pharmacists to screen for GI risk factors may help to sustain appropriate prescribing and reduce NSAID-related adverse events.


  • Open Access

    Health-related quality of life among older adults with arthritis

    by Kelli L Dominick, Frank M Ahern, Carol H Gold, Debra A Heller

    Health-related quality of life (HRQOL) is a key outcome in arthritis, but few population-based studies have examined the relationship of specific arthritic conditions, such as osteoarthritis (OA) and rheumatoid arthritis (RA) with HRQOL. Older adults in Pennsylvania completed a mail version of the Centers for Disease Control and Prevention (CDC) HRQOL modules. Medicare data were used to identify subjects with OA, RA, and no arthritis diagnosis. We compared HRQOL responses among these groups, and we also examined relationships of demographic characteristics to HRQOL among subjects with arthritis. In analyses controlling for demographic characteristics and comorbidity, subjects with OA and RA had poorer scores than those without arthritis on all HRQOL items, including general health, physical health, mental health, activity limitation, pain, sleep, and feeling healthy and full of energy. HRQOL scores were also lower for those with RA compared to OA. Among individuals with arthritis, all subject characteristics (including age, race, sex, nursing home residence, marital status, income, and comorbid illnesses) were significantly related to at least one HRQOL item. Older age, nursing home residence, and greater comorbidity were the most consistently associated with poorer HRQOL. Results of this study show that both OA and RA have a significant impact on multiple dimensions of HRQOL among older adults. Results also suggest the CDC HRQOL items are suitable for use among older adults and in mail surveys. Due to the rising number of older adults in many countries, the public health burden of arthritis is expected to increase dramatically. Efforts are needed to enhance access to medical care and disseminate self-management interventions for arthritis.